1.
Cell Stem Cell
; 23(5): 649-652, 2018 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30344101
RESUMO
Hundreds of clinics in India offer unproven stem cell therapies despite having remarkably stringent guidelines and regulations for fraudulent advertisements and clinical practice. We discuss the challenges with current regulations, how a recently proposed amendment may further legitimize unproven stem cell therapies, and discuss paths forward in a global context.